http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#head http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#assertion http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#provenance http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#assertion http://bio2rdf.org/drugbank:DB00227 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00227_DB00661 http://bio2rdf.org/drugbank:DB00661 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00227_DB00661 http://bio2rdf.org/drugbank_resource:DB00227_DB00661 http://purl.org/dc/terms/identifier drugbank_resource:DB00227_DB00661 http://bio2rdf.org/drugbank_resource:DB00227_DB00661 http://purl.org/dc/terms/title DDI between Lovastatin and Verapamil - Verapamil, a moderate CYP3A4 inhibitor, may increase the serum concentration of Lovastatin by decreasing its metabolism. Avoid concurrent use if possible or reduce lovastatin dose during concomitant therapy. Monitor for changes in the therapeutic/adverse effects of Lovastatin if Verapamil is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00227_DB00661 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00227_DB00661 http://www.w3.org/2000/01/rdf-schema#label DDI between Lovastatin and Verapamil - Verapamil, a moderate CYP3A4 inhibitor, may increase the serum concentration of Lovastatin by decreasing its metabolism. Avoid concurrent use if possible or reduce lovastatin dose during concomitant therapy. Monitor for changes in the therapeutic/adverse effects of Lovastatin if Verapamil is initiated, discontinued or dose changed. [drugbank_resource:DB00227_DB00661] http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#provenance http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#signature.MCwCFHz3whDqEN_n http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#signature.MCwCFHz3whDqEN_n http://purl.org/nanopub/x/hasSignature MCwCFHz3whDqEN/neJa/C51avII5oQFAAhRrSXbO4LJtA1Lpl98i7fKmorMKcQ== http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#signature.MCwCFHz3whDqEN_n http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://purl.org/dc/terms/created 2018-03-30T11:12:37.717+02:00 http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0#signature.MCwCFHz3whDqEN_n http://bio2rdf.org/drugbank_resource:DB00227_DB00661_nanopub.RAyFXvna-Uf-0jUrmn6fP-VLF_bKouHd4ect8LcJqc_h0 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234